Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx

Introduction<p>The safety concerns of Bruton's tyrosine kinase inhibitors (BTKis) have garnered significant attention due to their severe adverse reactions. However, no existing studies have utilized VigiBase, the world's largest adverse event reporting system, to conduct post-market...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Han Qu (4391905) (author)
Kolejni autorzy: Yuqi Jia (12074459) (author), Zizhen Liu (10067249) (author), Zuan Li (13285615) (author), Xin Zhao (71840) (author), Zhenghua Wu (548294) (author), Guorong Fan (2294386) (author), Yuefen Lou (11843792) (author)
Wydane: 2025
Hasła przedmiotowe:
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!